Ash Stevens

Piramal acquires Ash Stevens to strengthen its North American presence. The deal expands Piramal’s footprint in the pharmaceutical and biotech contract manufacturing sector. Ash Stevens specializes in sterile injectable drug production and development services.

Sep 2016Chemical & Engineering NewsNews article

Piramal Pharma Solutions is acquiring Ash Stevens, a provider of contract pharmaceutical drug substance development and API manufacturing services. The deal expands Piramal’s global pharmaceutical manufacturing capabilities. Ash Stevens serves customers in drug development and production, while Piramal operates as a leader in pharmaceutical manufacturing.

Aug 2016PR NewswireNews article

Piramal Enterprises Ltd. acquires Ash Stevens Inc., a U.S.-based contract development and manufacturing organization (CDMO), for up to $53 million in cash and earn-out payments. Ash Stevens operates a 60,000-sq.-ft. facility in Riverview, Michigan, equipped with eight drug development labs and six full-scale production areas. The deal includes engineering and containment controls for sterile manufacturing processes.

Aug 2016Contract PharmaNews article

Piramal acquires a Midwestern-based contract development and manufacturing organization (CDMO) in the U.S. The Indian drugmaker expands its American manufacturing footprint, following a previous purchase of a sterile manufacturing facility last year.

Aug 2016Fierce PharmaNews article